News >

Expert Highlights Immunotherapy Combo Strategies in Relapsed/Refractory CRC

Jessica Hergert
Published: Friday, Jan 10, 2020

A. Craig Lockhart, MD, MHS, a professor and associate director for Regional and Strategic Clinical Research Affiliations, Sylvester Comprehensive Cancer Center, University of Miami Health System

A. Craig Lockhart, MD, MHS

The explosion of immunotherapy in oncology has spread to the colorectal cancer (CRC) paradigm, which now has led investigators to evaluate combination approaches with this class of agents and others to elicit greater responses for patients with relapsed/refractory disease, said A. Craig Lockhart, MD, MHS.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication